Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(20%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
2
20%
Ph not_applicable
8
80%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(6)
Completed(3)
Other(1)

Detailed Status

Not yet recruiting4
Completed3
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (20.0%)
N/A8 (80.0%)

Trials by Status

not_yet_recruiting440%
completed330%
recruiting220%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10